These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

49 related items for PubMed ID: 19852061

  • 1. Adjuvant dendritic cell-based tumour vaccination for children with malignant brain tumours.
    Ardon H, De Vleeschouwer S, Van Calenbergh F, Claes L, Kramm CM, Rutkowski S, Wolff JE, Van Gool SW.
    Pediatr Blood Cancer; 2010 Apr; 54(4):519-25. PubMed ID: 19852061
    [Abstract] [Full Text] [Related]

  • 2. Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme.
    De Vleeschouwer S, Fieuws S, Rutkowski S, Van Calenbergh F, Van Loon J, Goffin J, Sciot R, Wilms G, Demaerel P, Warmuth-Metz M, Soerensen N, Wolff JE, Wagner S, Kaempgen E, Van Gool SW.
    Clin Cancer Res; 2008 May 15; 14(10):3098-104. PubMed ID: 18483377
    [Abstract] [Full Text] [Related]

  • 3. Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma.
    Yu JS, Liu G, Ying H, Yong WH, Black KL, Wheeler CJ.
    Cancer Res; 2004 Jul 15; 64(14):4973-9. PubMed ID: 15256471
    [Abstract] [Full Text] [Related]

  • 4. Cell therapies in neuro-oncology.
    Pellegatta S, Finocchiaro G.
    Neurol Sci; 2005 May 15; 26 Suppl 1():S43-5. PubMed ID: 15883693
    [Abstract] [Full Text] [Related]

  • 5. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
    Thorarinsdottir HK, Rood B, Kamani N, Lafond D, Perez-Albuerne E, Loechelt B, Packer RJ, MacDonald TJ.
    Pediatr Blood Cancer; 2007 Mar 15; 48(3):278-84. PubMed ID: 16456857
    [Abstract] [Full Text] [Related]

  • 6. Characterization of CD34+ progenitor-derived dendritic cells pulsed with tumor cell lysate for a vaccination strategy in children with malignant solid tumors and a poor prognosis.
    Ackermann B, Tröger A, Glouchkova L, Körholz D, Göbel U, Dilloo D.
    Klin Padiatr; 2004 Mar 15; 216(3):176-82. PubMed ID: 15175963
    [Abstract] [Full Text] [Related]

  • 7. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.
    Palucka AK, Ueno H, Connolly J, Kerneis-Norvell F, Blanck JP, Johnston DA, Fay J, Banchereau J.
    J Immunother; 2006 Mar 15; 29(5):545-57. PubMed ID: 16971810
    [Abstract] [Full Text] [Related]

  • 8. Clinical responses in patients with advanced colorectal cancer to a dendritic cell based vaccine.
    Burgdorf SK, Fischer A, Myschetzky PS, Munksgaard SB, Zocca MB, Claesson MH, Rosenberg J.
    Oncol Rep; 2008 Dec 15; 20(6):1305-11. PubMed ID: 19020707
    [Abstract] [Full Text] [Related]

  • 9. Immunotherapy in atypical teratoid-rhabdoid tumors: Data from a survey of the HGG-Immuno Group.
    van Gool SW, Holm S, Rachor J, Adamson L, Technau A, Maass E, Frühwald MC, Schlegel PG, Eyrich M.
    Cytotherapy; 2016 Sep 15; 18(9):1178-86. PubMed ID: 27421737
    [Abstract] [Full Text] [Related]

  • 10. Dendritic cells as potential adjuvant for immunotherapy in adrenocortical carcinoma.
    Papewalis C, Fassnacht M, Willenberg HS, Domberg J, Fenk R, Rohr UP, Schinner S, Bornstein SR, Scherbaum WA, Schott M.
    Clin Endocrinol (Oxf); 2006 Aug 15; 65(2):215-22. PubMed ID: 16886963
    [Abstract] [Full Text] [Related]

  • 11. [High dose chemotherapy with thiotepa, carboplatin, VP16 and autologous stem cell transplantation in treatment of malignant brain tumors with poor prognosis. Results of a mono-center pilot study].
    Fleischhack G, Pöpping K, Hasan C, Utsch B, Jüttner J, Bode U.
    Klin Padiatr; 1998 Aug 15; 210(4):248-55. PubMed ID: 9743961
    [Abstract] [Full Text] [Related]

  • 12. Long-term outcome of immunotherapy for patients with refractory pancreatic cancer.
    Nakamura M, Wada J, Suzuki H, Tanaka M, Katano M, Morisaki T.
    Anticancer Res; 2009 Mar 15; 29(3):831-6. PubMed ID: 19414316
    [Abstract] [Full Text] [Related]

  • 13. A pilot clinical trial of vaccination with dendritic cells pulsed with autologous tumor cells derived from malignant pleural effusion in patients with late-stage lung carcinoma.
    Chang GC, Lan HC, Juang SH, Wu YC, Lee HC, Hung YM, Yang HY, Whang-Peng J, Liu KJ.
    Cancer; 2005 Feb 15; 103(4):763-71. PubMed ID: 15637694
    [Abstract] [Full Text] [Related]

  • 14. HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities.
    Santin AD, Bellone S, Palmieri M, Ravaggi A, Romani C, Tassi R, Roman JJ, Burnett A, Pecorelli S, Cannon MJ.
    Gynecol Oncol; 2006 Mar 15; 100(3):469-78. PubMed ID: 16249018
    [Abstract] [Full Text] [Related]

  • 15. [Efficacy of autologous renal tumor cell lysate-loaded dendritic cell vaccine in combination with cytokine-induced killer cells on advanced renal cell carcinoma--a report of ten cases].
    Wang H, Zhou FJ, Wang QJ, Qin ZK, Huang LX, Liu ZW, Han H, Li YQ, Chen SP, Xia JC.
    Ai Zheng; 2006 May 15; 25(5):625-30. PubMed ID: 16687087
    [Abstract] [Full Text] [Related]

  • 16. Sensitization of malignant glioma to chemotherapy through dendritic cell vaccination.
    Liu G, Black KL, Yu JS.
    Expert Rev Vaccines; 2006 Apr 15; 5(2):233-47. PubMed ID: 16608423
    [Abstract] [Full Text] [Related]

  • 17. A phase I trial of surgical resection with Gliadel Wafer placement followed by vaccination with dendritic cells pulsed with tumor lysate for patients with malignant glioma.
    Rudnick JD, Sarmiento JM, Uy B, Nuno M, Wheeler CJ, Mazer MJ, Wang H, Hu JL, Chu RM, Phuphanich S, Black KL, Yu JS.
    J Clin Neurosci; 2020 Apr 15; 74():187-193. PubMed ID: 32169363
    [Abstract] [Full Text] [Related]

  • 18. Vaccine therapy in patients with renal cell carcinoma.
    Van Poppel H, Joniau S, Van Gool SW.
    Eur Urol; 2009 Jun 15; 55(6):1333-42. PubMed ID: 19201522
    [Abstract] [Full Text] [Related]

  • 19. Phase II study of oxaliplatin in children with recurrent or refractory medulloblastoma, supratentorial primitive neuroectodermal tumors, and atypical teratoid rhabdoid tumors: a pediatric brain tumor consortium study.
    Fouladi M, Blaney SM, Poussaint TY, Freeman BB, McLendon R, Fuller C, Adesina AM, Hancock ML, Danks MK, Stewart C, Boyett JM, Gajjar A.
    Cancer; 2006 Nov 01; 107(9):2291-7. PubMed ID: 17019740
    [Abstract] [Full Text] [Related]

  • 20. Outcome of secondary high-grade glioma in children previously treated for a malignant condition: a study of the Canadian Pediatric Brain Tumour Consortium.
    Carret AS, Tabori U, Crooks B, Hukin J, Odame I, Johnston DL, Keene DL, Freeman C, Bouffet E, Canadian Pediatric Brain Tumour Consortium.
    Radiother Oncol; 2006 Oct 01; 81(1):33-8. PubMed ID: 16973227
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.